D-0849-2020 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-0849-2020 was initiated by American Health Packaging on Feb 7, 2020 and is designated Class II. Reason for recall: GMP Deviations: Product bottle may be absent of desiccant. The recall status is terminated (terminated Aug 4, 2022). Affected quantity: 3,720 cartons.

Recall details

Product Type
Drugs
Report Date
Feb 26, 2020
Initiation Date
Feb 7, 2020
Termination Date
Aug 4, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,720 cartons

Product description

Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged and distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-604-21; NDC Unit Dose 68084-604-11

Reason for recall

GMP Deviations: Product bottle may be absent of desiccant.

Distribution pattern

Nationwide USA

Code information

Lot 180510, exp 3/31/2020; Lot 181912, exp 4/30/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0849-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0849-2020. Report a data issue: hello@regdatalab.com.